Stocks Health care OABI
NASDAQ · Health careOmniAb, Inc. (OABI)
OmniAb, Inc. brought in $40.2M of revenue over the twelve months to September 30, 2026, up 90.6% from a year earlier. It posted a net loss of $43.5M. In fiscal 2025 capital spending exceeded operating cash flow by $37M. At September 30, 2026 it held $22.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 30, 2026.
Key facts about OmniAb, Inc.
- Net worth
- OmniAb, Inc. has a market value (market cap) of $770.6M at the latest share price, and shareholders' equity of $249.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $18.7M (-29.3% year on year), with a net loss of $64.8M. Over the 12 months to September 30, 2026: revenue $40.2M, net loss $43.5M.
- Cash flow
- In fiscal 2025 operations used $36.5M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 30, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- OmniAb, Inc.'s next report is expected around March 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
- Dividend
- OmniAb, Inc. declared dividends of $2.50 per share in fiscal 2007.
What OmniAb, Inc. does
OmniAb, Inc. is registered with the SEC under industry code SIC 8731 (Services-Commercial Physical & Biological Research). Its shares trade on NASDAQ under the ticker OABI.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $18.7M | -$64.8M | -$0.57 | -$37M |
| 2024 | $26.4M | -$62M | -$0.61 | -$41.5M |
| 2023 | $34.2M | -$50.6M | -$0.51 | $703K |
| 2022 | $59.1M | -$22.3M | -$0.26 | -$20.8M |
| 2021 | $34.7M | -$27M | -$0.33 | -$9.7M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where OABI ranks in Health care
Dividends
OmniAb, Inc. declared $2.50 per share in fiscal 2007.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2007 | $2.50 | n/a | n/a |
Latest SEC filings
What OmniAb, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 30, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 78% to $4M versus the same quarter last year; diluted EPS -$0.12 versus -$0.14.
- October 30, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 244% to $13.4M versus the same quarter last year; diluted EPS -$0.05 versus -$0.15.
- August 6, 2026
- July 13, 2026
- June 18, 2026
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 247% to $14.4M versus the same quarter last year; diluted EPS -$0.06 versus -$0.17.
- May 7, 2026
- April 29, 2026
Insider trades
What the people running OmniAb, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 1, 2026 | Love StevenDirector | Exercised options | 13,334 | - |
| June 17, 2026 | Higgins John LDirector | Exercised options | 20,000 | - |
| June 17, 2026 | Love StevenDirector | Exercised options | 20,000 | - |
| June 17, 2026 | Bertozzi Carolyn RDirector | Exercised options | 20,000 | - |
| June 17, 2026 | Cochran Jennifer R.Director | Exercised options | 20,000 | - |
| June 17, 2026 | Gotwals Philip JDirector | Exercised options | 20,000 | - |
| June 17, 2026 | Crouse Steven C.Director | Exercised options | 20,000 | - |
| April 21, 2026 | Gotwals Philip JDirector | Exercised options | 13,333 | - |
Who owns OABI
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Thompson Dean13D, may seek influence with 5 related filers | 21.1% | July 2, 2024 |
| Robert Goldstein13G, passive with 7 related filers | 8.5% | February 10, 2026 |
| Whitefort Capital Management, LP13G, passive with 2 related filers | 7.1% | August 14, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 131 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Whitefort Capital Management, LP | 10,248,658 | -3,975,000 |
| BlackRock, Inc. | 8,897,490 | +790,609 |
| Nomura Holdings Inc | 5,028,160 | +4,323,112 |
| Cadian Capital Management, LP | 4,211,821 | +54,692 |
| Vanguard Capital Management LLC | 3,852,356 | -141,296 |
| Geode Capital Management, LLC | 2,883,978 | -41,601 |
| Rice Hall James & Associates, LLC | 2,610,434 | +63,179 |
| Private Management Group Inc | 2,344,770 | -84,396 |
| State Street Corp | 2,133,549 | +66,406 |
| Dimensional Fund Advisors LP | 1,262,099 | -483,149 |
| Towerview LLC | 1,180,000 | +180,000 |
| Vanguard Portfolio Management LLC | 980,416 | +76,617 |
| Charles Schwab Investment Management Inc | 966,877 | +7,304 |
| Northern Trust Corp | 948,294 | +67,399 |
| ADAR1 Capital Management, LLC | 947,412 | +242,222 |
| Isthmus Partners, LLC | 803,428 | +46,754 |
| Vanguard Fiduciary Trust Co | 758,460 | +32,852 |
| Two Sigma Investments, LP | 657,432 | +144,691 |
| Nuveen, LLC | 642,811 | +18,935 |
| Renaissance Technologies LLC | 600,350 | +330,750 |
Insiders
9 insiders reported holding 8,513,628 shares in total, about $45.1M at the last price.
| Holder | Shares |
|---|---|
| Foehr Matthew WPresident and CEO, Director | 4,420,492 |
| Higgins John LDirector | 2,962,320 |
| Berkman Charles SChief Legal Officer | 399,085 |
| Gustafson Kurt AExecutive VP, Finance and CFO | 261,483 |
| Cochran Jennifer R.Director | 185,274 |
| Bertozzi Carolyn RDirector | 113,308 |
| Love StevenDirector | 105,000 |
| Gotwals Philip JDirector | 33,333 |
| Crouse Steven C.Director | 33,333 |
Questions about OABI
What does OmniAb, Inc. do?
OmniAb, Inc. is a company in the Health care sector, listed on NASDAQ as OABI. Its shares trade on NASDAQ under the ticker OABI.
What is OmniAb, Inc.'s net worth?
OmniAb, Inc. has a market value (market cap) of $770.6M at the latest share price, and shareholders' equity of $249.2M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is OmniAb, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $43.5M on revenue of $40.2M.
How much revenue does OmniAb, Inc. make?
Over the twelve months to September 30, 2026 OmniAb, Inc. reported revenue of $40.2M. That is 90.6% more than a year earlier.
When did OmniAb, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 30, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the insider trade from November 2, 2026.
When is OmniAb, Inc.'s next earnings report?
OmniAb, Inc.'s next report is expected around March 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Does OmniAb, Inc. pay a dividend?
Yes. OmniAb, Inc. declared dividends of $2.50 per share in fiscal 2007.
Similar companies
Compare OABI with
Follow OABI
Get an email when OmniAb, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values OmniAb, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.